ASAlyssa R. Summers

Alyssa R. Summers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alyssa R. Summers has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Histone Deacetylase 3 Is Required for Efficient T Cell Development

    by Kristy R. Stengel, Yue Zhao, Nicholas J. Klus, Jonathan F. Kaiser, Laura E. Gordy, Sebastian Joyce, Scott W. Hiebert, Alyssa R. Summers

    Hdac3 is a key target for Hdac inhibitors that are efficacious in cutaneous T cell lymphoma. Moreover, the regulation of chromatin structure is critical as thymocytes transition from an immature cell with open chromatin to a mature T cell with tightly condensed chromatin. To define the phenotypes controlled by Hdac3 during T cell development, we conditionally deleted Hdac3 using the Lck-Cre transgene. This strategy inactivated Hdac3 in the double negative stages of thymocyte development and caused a significant impairment at the CD8 immature single positive stage (ISP) and CD4/CD8 double positive stage with few mature CD4+ or CD8+ single positive cells being produced. When the Hdac3-/- mice were crossed with Bcl-xL, Bcl2, or TCRβ-expressing transgenic mice, a modest level of complementation was found. However, when the null mice were crossed with mice expressing a fully rearranged TCRαβ transgene, normal levels of CD4 single positive cells were produced. Thus, Hdac3 was required for efficient transit from double negative stage 4 through positive selection.